Opening book details…
About this Medicine article
Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial by Cheng, Ying; Han, Baohui; Li, Kai; Wang, Qiming; Zhang, Li; Shi, Jianhua; Wang, Zhehai; He, Jianxing; Shi, Yuankai; Chen, Weiqiang; Wang, Xiuwen; Luo, Yi; Nan, Kejun; Jin, Faguang; Li, Baolan; Zhu, Jing is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Cheng, Ying; Han, Baohui; Li, Kai; Wang, Qiming; Zhang, Li; Shi, Jianhua; Wang, Zhehai; He, Jianxing; Shi, Yuankai; Chen, Weiqiang; Wang, Xiuwen; Luo, Yi; Nan, Kejun; Jin, Faguang; Li, Baolan; Zhu, Jing
- Publisher
- Wiley (John Wiley & Sons); John Wiley and Sons Ltd; Oxford: Blackwell Publishing; [Chichester]: 2013-; Wiley (ISSN 2045-7634)
- Published
- 2020
- Field
- Medicine (Health Sciences)